These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18614419)

  • 1. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
    Thimmasetty J; Pandey G; Babu P
    Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of mucoadhesive patches for buccal administration of carvedilol.
    Vishnu YV; Chandrasekhar K; Ramesh G; Rao YM
    Curr Drug Deliv; 2007 Jan; 4(1):27-39. PubMed ID: 17269915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro evaluation of buccoadhesive carvedilol tablets.
    Yamsani VV; Gannu R; Kolli C; Rao ME; Yamsani MR
    Acta Pharm; 2007 Jun; 57(2):185-97. PubMed ID: 17507315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminated sponges as challenging solid hydrophilic matrices for the buccal delivery of carvedilol microemulsion systems: Development and proof of concept via mucoadhesion and pharmacokinetic assessments in healthy human volunteers.
    Abd-Elbary A; Makky AM; Tadros MI; Alaa-Eldin AA
    Eur J Pharm Sci; 2016 Jan; 82():31-44. PubMed ID: 26546947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.
    Yedurkar P; Dhiman MK; Petkar K; Sawant K
    J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of mucoadhesive buccal patches of flurbiprofen.
    Mishra SK; Garud N; Singh R
    Acta Pol Pharm; 2011; 68(6):955-64. PubMed ID: 22125962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of cellulose-polymethacrylate mucoadhesive film for buccal delivery of carvedilol.
    Meher JG; Tarai M; Yadav NP; Patnaik A; Mishra P; Yadav KS
    Carbohydr Polym; 2013 Jul; 96(1):172-80. PubMed ID: 23688467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P; Murthy RS
    Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
    Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
    PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V; Dhar S; Mandpe L
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of carvedilol transdermal patches.
    Tanwar YS; Chauhan CS; Sharma A
    Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled liposome from multi-layered fibrous mucoadhesive membrane for buccal delivery of drugs having high first-pass metabolism.
    Chen J; Pan H; Yang Y; Xiong S; Duan H; Yang X; Pan W
    Int J Pharm; 2018 Aug; 547(1-2):303-314. PubMed ID: 29803794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol-loaded nanocapsules: Mucoadhesive properties and permeability across the sublingual mucosa.
    Chaves PD; Ourique AF; Frank LA; Pohlmann AR; Guterres SS; Beck RC
    Eur J Pharm Biopharm; 2017 May; 114():88-95. PubMed ID: 28119104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buccal films of prednisolone with enhanced bioavailability.
    Kumria R; Nair AB; Goomber G; Gupta S
    Drug Deliv; 2016; 23(2):471-8. PubMed ID: 24892626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of carvedilol compression coated tablet.
    Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D
    Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of controlled release bioerodable anti infective ophthalmic insert.
    Thakur R; Swami G; Rahman M
    Curr Drug Deliv; 2014; 11(1):2-10. PubMed ID: 22283654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery.
    Meng X; Li P; Wei Q; Zhang HX
    Pharm Dev Technol; 2011 Feb; 16(1):22-8. PubMed ID: 20028209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.